Ahmed Abdel
Expertise in
3
conditions

Dr. Ahmed Abdel

Cardiology
University Of Michigan Medical Center
1500 E Medical Center Dr, 
Ann Arbor, MI 
Expertise in
3
conditions
University Of Michigan Medical Center
1500 E Medical Center Dr, 
Ann Arbor, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ahmed Abdel is a Cardiologist in Ann Arbor, Michigan. Dr. Abdel is highly rated in 3 conditions, according to our data. His top areas of expertise are Heart Attack, Heart Failure, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Atherectomy.

His clinical research consists of co-authoring 143 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Internal Medicine in KY
Hospital Affiliations
University Of Michigan Health System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
View 1 Less Insurance Carrier -

Locations

University of Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor, MI 48109
Other Locations
Regents of the University of Michigan
3621 S State St, Ann Arbor, MI 48108

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Enrollment Status: Completed
Publish Date: January 10, 2022
Intervention Type: Biological, Other
Study Phase: Phase 3
Periprocedural Cangrelor in Patients With ST-Elevation Myocardial Infarction to Reduce Development of Myocardial Necrosis
Periprocedural Cangrelor in Patients With ST-Elevation Myocardial Infarction to Reduce Development of Myocardial Necrosis
Enrollment Status: Terminated
Publish Date: June 30, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

142 Total Publications

Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEF.
Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEF.
Journal: bioRxiv : the preprint server for biology
Published: December 11, 2025
Similar Doctors
Kim Eagle
Expertise in
40
conditions
Dr. Kim Eagle
Cardiology
Expertise in
40
conditions
Dr. Kim Eagle
Cardiology

Office

4029 Maria St Ste A, 
Ann Arbor, MI 
 (3.4 miles away)
888-287-1082
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kim Eagle is a Cardiologist in Ann Arbor, Michigan. Dr. Eagle is highly rated in 40 conditions, according to our data. His top areas of expertise are Aortic Dissection, Marfan Syndrome, Thoracic Aortic Aneurysm, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

Expertise in
30
conditions
Dr. Sara Saberi
Cardiology
Expertise in
30
conditions
Dr. Sara Saberi
Cardiology

Office

1425 E Ann St Spc 5856, 
Ann Arbor, MI 
 (1.1 miles away)
888-287-1082
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sara Saberi is a Cardiologist in Ann Arbor, Michigan. Dr. Saberi is highly rated in 30 conditions, according to our data. Her top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation.

Vallerie Mclaughlin
Expertise in
12
conditions
Dr. Vallerie Mclaughlin
Cardiology
Expertise in
12
conditions
Dr. Vallerie Mclaughlin
Cardiology

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor, MI 
 (0.2 miles away)
888-287-1082
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vallerie Mclaughlin is a Cardiologist in Ann Arbor, Michigan. Dr. Mclaughlin is highly rated in 12 conditions, according to our data. Her top areas of expertise are Pulmonary Hypertension, Hypertension, Systemic Sclerosis (SSc), Angioplasty, and Heart Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Abdel's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile